Chart of the Day - Regeneron Pharmaceuticals (REGN)

The "Chart of the Day" is Regeneron Pharmaceuticals (REGN), which showed up on Wednesday's Barchart "All Time High" list. Regeneron on Wednesday posted a new all-time high of $83.14 and closed up 4.39%. TrendSpotter has been Long since Jan 5 at $60.94. In recent news on the stock, Roth Capital downgraded Regeneron to Neutral from Buy with a target of $78 on valuation concerns. Regeneron on Jan 10 rallied 14.9% after Eylea sales beat expectations. RW Baird on Jan 10 upgraded Regeneron to Outperform from Neutral and raised its target to $81 from $56. Regeneron Pharmaceuticals, with a market cap of $7.2 billion, is a biopharmaceutical company that discovers, develops, and commercializes therapeutic drugs for the treatment of serious medical conditions.